Showing results (11-20 of 109) with videos related to
Sort By:
Pageof 11
Arthritis Research & Therapy|October 6, 2017
Ultrasound of the hand is sufficient to detect subclinical inflammation in rheumatoid arthritis remission: a post hoc longitudinal studyHilde Berner Hammer, Tore K Kvien, Lene TerslevAnnals of the Rheumatic Diseases|December 16, 2006
Ultrasonographic measurement of the median nerve in patients with rheumatoid arthritis without symptoms or signs of carpal tunnel syndromeHilde Berner Hammer, Espen A Haavardsholm, Tore Kristian KvienArthritis Research & Therapy|October 5, 2018
Is synovial hypertrophy without Doppler activity sensitive to change? Post-hoc analysis from a rheumatoid arthritis ultrasound studyLene Terslev, Mikkel Østergaard, Joe Sexton, et al.Annals of the Rheumatic Diseases|May 18, 2010
A 78-joints ultrasonographic assessment is associated with clinical assessments and is highly responsive to improvement in a longitudinal study of patients with rheumatoid arthritis starting adalimumab treatmentHilde Berner Hammer, Margareth Sveinsson, Anne Katrine Kongtorp, et al.Arthritis Research & Therapy|October 28, 2011
The soluble biomarker calprotectin (an S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumabHilde Berner Hammer, Magne K Fagerhol, Tale Norbye Wien, et al.Annals of the Rheumatic Diseases|November 21, 2025
Ultrasound-detected crystal depositions and clinical flares dissolve during successful urate-lowering therapy: 5-year follow-up results from the treat-to-target NOR-Gout studyHilde Berner Hammer, Lars Karoliussen, Lene Terslev, et al.Scandinavian Journal of Clinical and Laboratory Investigation|December 28, 2017
Calprotectin (S100A8/A9) should preferably be measured in EDTA-plasma; results from a longitudinal study of patients with rheumatoid arthritisHilde Haugedal Nordal, Magne K Fagerhol, Anne-Kristine Halse, et al.RMD Open|November 20, 2020
Trajectories of fatigue in actively treated patients with established rheumatoid arthritis starting biologic DMARD therapySella Aarrestad Provan, Brigitte Michelsen, Joseph Sexton, et al.Clinical Rheumatology|October 11, 2020
Fatigue is cross-sectionally not associated with objective assessments of inflammation, but changes in fatigue are associated with changes of disease activity assessments during biologic treatment of patients with established rheumatoid arthritisHilde Berner Hammer, Brigitte Michelsen, Joe Sexton, et al.Seminars in Arthritis and Rheumatism|July 7, 2024
Ultrasound evaluation contrasts clinical disease activity evaluation in rheumatoid arthritis patients with concomitant anxiety or depressionBrigitte Michelsen, Joseph Sexton, Tore K Kvien, et al.Pageof 11